Gudrun Schleiermacher researcher
Schleiermacher, Gudrun
VIAF ID: 213150832 (Personal)
Permalink: http://viaf.org/viaf/213150832
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Accumulation of Segmental Alterations Determines Progression in Neuroblastoma |
![]() |
Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma |
![]() |
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome |
![]() |
Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis |
![]() |
Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes |
![]() |
Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastoma |
![]() |
Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis |
![]() |
Clinical characteristics and outcome of patients with neuroblastoma harbouring genomic amplification of loci other than MYCN. |
![]() |
Contribution of two parental imprinted microRNA clusters in tumor progression and prognosis of neuroblastoma. |
![]() |
Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data |
![]() |
Etude clinique de patients présentant un neuroblastome avec amplification génomique autre que MYCN |
![]() ![]() |
Etude de la sensibilité aux drogues et de l'évolution clonale sous thérapies ciblées du neuroblastome de haut risque. |
![]() |
Etude des translocations déséquilibrées du chromosome 17q dans le neuroblastome |
![]() ![]() |
EVALUATION DE L'INHIBITION DE L'ANGIOGENESE DANS LE NEUROBLASTOME ET CARACTERISATION DE MECANISMES DE RESISTANCE |
![]() |
EXPLORATION OF ANGIOGENESIS INHIBITION IN NEUROBLASTOMA AND CHARACTERIZATION OF ESCAPE MECHANISMS. |
![]() |
Facteurs de risque périnataux et environnementaux des neuroblastomes de l'enfant. |
![]() |
Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors. |
![]() |
From class waivers to precision medicine in paediatric oncology. |
![]() |
[Genetic alterations in neuroblastoma and their usefulness for clinical management] |
![]() |
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. |
![]() |
Learning smoothing models of copy number profiles using breakpoint annotations |
![]() |
Liquid Biopsy in Pediatric Sarcoma |
![]() |
Management of renal tumors in children : initial pretreatment biopsy : a single-center retrospective review of 317 children. |
![]() |
Meta-mining of copy number profiles of high-risk neuroblastoma tumors |
![]() |
Minimally invasive surgery of neuroblastic tumors in children: Indications depend on anatomical location and image-defined risk factors |
![]() |
Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma. |
![]() |
Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations. |
![]() |
Opsoclonus-myoclonus in children associated or not with neuroblastoma. |
![]() |
Overall genomic pattern is a predictor of outcome in neuroblastoma |
![]() |
Parental smoking, maternal alcohol consumption during pregnancy and the risk of neuroblastoma in children. A pooled analysis of the ESCALE and ESTELLE French studies |
![]() |
Pediatric Patient With Renal Cell Carcinoma Treated by Successive Antiangiogenics Drugs: A Case Report and Review of the Literature |
![]() |
Perinatal and environmental risk factors of childhood neuroblastoma |
![]() |
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study |
![]() |
Preferential occurrence of chromosome breakpoints within early replicating regions in neuroblastoma |
![]() |
Prise en charge des tumeurs rénales de l’enfant : place de la biopsie dans la prise en charge initiale, analyse rétrospective d’une cohorte monocentrique de 317 enfants |
![]() |
Prognostic impact of gene expression-based classification for neuroblastoma. |
![]() |
QuantumClone: Clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction. |
![]() |
Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival. |
![]() |
Recent insights into the biology of neuroblastoma |
![]() |
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations |
![]() |
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers |
![]() |
SegAnnDB: interactive Web-based genomic segmentation |
![]() |
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence |
![]() |
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma |
![]() |
Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain. |
![]() |
Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma |
![]() |
Subclonal evolution in neuroblastoma. |
![]() ![]() |
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets |
![]() |
Use of Circulating DNA for the Study of Tumor Heterogeneity and Clonal Evolution in Pediatric Oncology. |
![]() |
Utilisation de l'ADN circulant pour l'étude de l'hétérogénéité tumorale et l'évolution clonale en oncologie pédiatrique |
![]() |
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma |
![]() |